Lactobacillus casei ATCC 393 combined with vasoactive intestinal peptide alleviates dextran sodium sulfate-induced ulcerative colitis in C57BL/6 mice via NF-κB and Nrf2 signaling pathways

Xu, 2022, Berberine ameliorates dextran sulfate sodium-induced ulcerative colitis and inhibits the secretion of gut lysozyme via promoting autophagy, Metabolites, 12, 10.3390/metabo12080676 Akiho, 2015, Promising biological therapies for ulcerative colitis: a review of the literature, World J. Gastrointest. Pathophysiol., 6, 219, 10.4291/wjgp.v6.i4.219 Gao, 2021, Brilliant glycans and glycosylation: seq and ye shall find, Int. J. Biol. Macromol., 189, 279, 10.1016/j.ijbiomac.2021.08.054 Bruscoli, 2021, Glucocorticoid therapy in inflammatory Bowel disease: mechanisms and clinical practice, Front. Immunol., 12, 10.3389/fimmu.2021.691480 Qiao, 2020, Lactobacillus salivarius alleviates inflammation via NF-kappaB signaling in ETEC K88-induced IPEC-J2 cells, J. Anim. Sci. Biotechnol., 11, 76, 10.1186/s40104-020-00488-5 Liu, 2016, Ursolic acid protects against ulcerative colitis via anti-inflammatory and antioxidant effects in mice, Mol. Med. Rep., 13, 4779, 10.3892/mmr.2016.5094 Zeng, 2021, Internal connections between dietary intake and gut microbiota homeostasis in disease progression of ulcerative colitis: a review, Food Sci. . Human. Wellness, 10, 119, 10.1016/j.fshw.2021.02.016 Shen, 2018, Relationship between intestinal microbiota and ulcerative colitis: mechanisms and clinical application of probiotics and fecal microbiota transplantation, World J. Gastroenterol., 24, 5, 10.3748/wjg.v24.i1.5 Shen, 2014, Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials, Inflamm. Bowel Dis., 20, 21, 10.1097/01.MIB.0000437495.30052.be Santos Rocha, 2012, Anti-inflammatory properties of dairy lactobacilli, Inflamm. Bowel Dis., 18, 657, 10.1002/ibd.21834 Hughes, 2017, Bifidobacterium breve reduces apoptotic epithelial cell shedding in an exopolysaccharide and MyD88-dependent manner, Open Biol., 7, 10.1098/rsob.160155 Cain, 2011, Clinical utility of probiotics in inflammatory bowel disease, Altern. Ther. Health Med., 17, 72 Marcone, 2017, Milk-derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis, Br. J. Clin. Pharmacol., 83, 152, 10.1111/bcp.13002 Xu, 2020, Lactobacillus casei ATCC 393 alleviates enterotoxigenic Escherichia coli K88-induced intestinal barrier dysfunction via TLRs/mast cells pathway, Life Sci., 244, 10.1016/j.lfs.2020.117281 Roy, 2017, Distinct microbial communities trigger colitis development upon intestinal barrier damage via innate or adaptive immune cells, Cell Rep., 21, 994, 10.1016/j.celrep.2017.09.097 Mssillou, 2020, Chemical composition, antioxidant activity, and antifungal effects of essential oil from Laurus nobilis L. flowers growing in Morocco, J. Food Qual., 2020, 10.1155/2020/8819311 Chen, 2019, Therapeutic effects of Lactobacillus paracasei subsp. paracasei NTU 101 powder on dextran sulfate sodium-induced colitis in mice, J. Food Drug Anal., 27, 83, 10.1016/j.jfda.2018.05.004 J. Wan Y. Zhang N. He Intestinal microecology in inflammatory bowel disease doi: 10.3760/CMA.J.ISSN.2096-367X.2019.03.001. Qu, 2021, Kaempferol alleviates murine experimental colitis by restoring gut microbiota and inhibiting the LPS-TLR4-NF-κB axis, Front. Immunol., 12, 10.3389/fimmu.2021.679897 Deng, 2021, Lactobacillus casei protects intestinal mucosa from damage in chicks caused by Salmonella pullorum via regulating immunity and the Wnt signaling pathway and maintaining the abundance of gut microbiota, Poult. Sci., 100, 10.1016/j.psj.2021.101283 Gutiérrez-Cañas, 2006, VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts, Rheumatol. (Oxf.), 45, 527, 10.1093/rheumatology/kei219 Delgado, 2001, Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease, Nat. Med., 7, 563, 10.1038/87887 Abad, 2003, Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease, Gastroenterology, 124, 961, 10.1053/gast.2003.50141 Sun, 2020, Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells, World J. Gastroenterol., 26, 7593, 10.3748/wjg.v26.i48.7593 Spoorthi, 2020, J. Dig. Dis., 21, 711, 10.1111/1751-2980.12932 Fujimori, 2011, Vasoactive intestinal peptide reduces oxidative stress in pancreatic acinar cells through the inhibition of NADPH oxidase, Peptides, 32, 2067, 10.1016/j.peptides.2011.08.027 Jönsson, 2012, Epithelial expression of vasoactive intestinal peptide in ulcerative colitis: down-regulation in markedly inflamed colon, Dig. Dis. Sci., 57, 303, 10.1007/s10620-011-1985-3 Wirtz, 2017, Chemically induced mouse models of acute and chronic intestinal inflammation, Nat. Protoc., 12, 1295, 10.1038/nprot.2017.044 Xu, 2022, Berberine ameliorates dextran sulfate sodium-induced ulcerative colitis and inhibits the secretion of gut lysozyme via promoting autophagy, Metabolites, 8, 676, 10.3390/metabo12080676 Conner, 1997, Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis, J. Pharm. Exp. Ther., 282, 1615 Ostanin, 2006, T cell-induced inflammation of the small and large intestine in immunodeficient mice, Am. J. Physiol. Gastrointest. Liver Physiol., 290, G109, 10.1152/ajpgi.00214.2005 Zundler, 2016, Integrating immunologic signaling networks: the JAK/STAT pathway in colitis and colitis-associated cancer, Vaccin. (Basel), 4 Nanda Kumar, 2008, Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate, J. Gastroenterol. Hepatol., 23, 1834, 10.1111/j.1440-1746.2008.05723.x Fedorak, 2009, Probiotics in ulcerative colitis, 181 Saniabadi, 2014, Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs, World J. Gastroenterol., 20, 9699, 10.3748/wjg.v20.i29.9699 Argyri, 2013, Selection of potential probiotic lactic acid bacteria from fermented olives by in vitro tests, Food Microbiol., 33, 282, 10.1016/j.fm.2012.10.005 Sarowska, 2013, The therapeutic effect of probiotic bacteria on gastrointestinal diseases, Adv. Clin. Exp. Med., 22, 759 Je, 2018, The probiotic, ID-JPL934, attenuates dextran sulfate sodium-induced colitis in mice through inhibition of proinflammatory cytokines expression, J. Med. Food, 21, 858, 10.1089/jmf.2017.4152 Bron, 2017, Can probiotics modulate human disease by impacting intestinal barrier function?, Br. J. Nutr., 117, 93, 10.1017/S0007114516004037 Hu, 2020, Preventive effect of Lactobacillus acidophilus XY27 on DSS-induced ulcerative colitis in mice, Drug Des. Dev. Ther., 14, 5645, 10.2147/DDDT.S284422 Lin, 2000, Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356, Dig. Dis. Sci., 45, 1617, 10.1023/A:1005577330695 Akoglu, 2015, Probiotic Lactobacillus casei Shirota improves kidney function, inflammation and bowel movements in hospitalized patients with acute gastroenteritis – a prospective study, J. Funct. Foods, 17, 305, 10.1016/j.jff.2015.05.021 Zhai, 2019, Synergy between probiotic Lactobacillus casei and milk to maintain barrier integrity of intestinal epithelial cells, J. Agric. Food Chem., 67, 1955, 10.1021/acs.jafc.8b06657 Bellavia, 2014, Lactobacillus casei and bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2,4,6-trinitrobenzenesulfonic acid treatment in mice, J. Biol. Regul. Homeost. Agents, 28, 251 Qiu, 2020, Maresin 1 alleviates dextran sulfate sodium-induced ulcerative colitis by regulating NRF2 and TLR4/NF-κB signaling pathway, Int. Immunopharmacol., 78, 10.1016/j.intimp.2019.106018 Saber, 2019, Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NF-κB and Nrf-2/HO-1 signaling crosstalk, Toxicol. Appl. Pharmacol., 364, 120, 10.1016/j.taap.2018.12.020 Rackaityte, 2020, The human microbiome in the 21(st) century, Nat. Commun., 11, 5256, 10.1038/s41467-020-18983-8 Nishida, 2018, Gut microbiota in the pathogenesis of inflammatory bowel disease, Clin. J. Gastroenterol., 11, 1, 10.1007/s12328-017-0813-5 Mishima, 2020, Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases, J. Gastroenterol., 55, 4, 10.1007/s00535-019-01618-1 Schirmer, 2019, Microbial genes and pathways in inflammatory bowel disease, Nat. Rev. Microbiol., 17, 497, 10.1038/s41579-019-0213-6 Zhang, 2019, Process design of the antioxidant shuidouchi and its effect on preventing dextran sulfate sodium (DSS)-induced colitis in mice via antioxidant activity, Appl. Sci., 9, 5, 10.3390/app9010005 Wu, 2015, Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice, PLoS One, 10 Morampudi, 2015, Vasoactive intestinal peptide prevents PKCε-induced intestinal epithelial barrier disruption during EPEC infection, Am. J. Physiol. Gastrointest. Liver Physiol., 308, 389, 10.1152/ajpgi.00195.2014 Song, 2012, VIP enhances phagocytosis of fibrillar beta-amyloid by microglia and attenuates amyloid deposition in the brain of APP/PS1 mice, PLoS One, 7 Surrenti, 1993, Colonic vasoactive intestinal polypeptide in ulcerative colitis, J. Physiol. Paris, 87, 307, 10.1016/0928-4257(93)90037-T Gonzalez-Rey, 2005, Role of vasoactive intestinal peptide in inflammation and autoimmunity, Curr. Opin. Investig. Drugs, 6, 1116 Gonzalez-Rey, 2006, Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide, Gastroenterology, 131, 1799, 10.1053/j.gastro.2006.10.023 Delgado, 2002, Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases, J. Mol. Med. (Berl.), 80, 16, 10.1007/s00109-001-0291-5 Eissa, 2017, Chromofungin (CHR: CHGA (47-66)) is downregulated in persons with active ulcerative colitis and suppresses pro-inflammatory macrophage function through the inhibition of NF-κB signaling, Biochem. Pharmacol., 145, 102, 10.1016/j.bcp.2017.08.013 Lim, 2015, Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-κB and MAPK activation and restoring Th17/Treg cell balance, Int. Immunopharmacol., 25, 493, 10.1016/j.intimp.2015.02.016 Wang, 2019, Protective effect of methane-rich saline on acetic acid-induced ulcerative colitis via blocking the TLR4/NF-κB/MAPK pathway and promoting IL-10/JAK1/STAT3-mediated anti-inflammatory response, Oxid. Med. Cell. Longev., 2019, 7850324 Liu, 2021, Aloe polysaccharides ameliorate acute colitis in mice via Nrf2/HO-1 signaling pathway and short-chain fatty acids metabolism, Int. J. Biol. Macromol., 185, 804, 10.1016/j.ijbiomac.2021.07.007 Bromage, 2022, Nrf2 attenuates the innate immune response after experimental myocardial infarction, Biochem. Biophys. Res. Commun., 606, 10, 10.1016/j.bbrc.2022.03.043 Chang, 2014, Heme oxygenase-1 counteracts contrast media-induced endothelial cell dysfunction, Biochem. Pharmacol., 87, 303, 10.1016/j.bcp.2013.11.002 Ismail Abo El-Fadl, 2022, Targeting endoplasmic reticulum stress, Nrf-2/HO-1, and NF-κB by myristicin and its role in attenuation of ulcerative colitis in rats, Life Sci., 311, 10.1016/j.lfs.2022.121187